Atlas Trials

Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5mg and Glimepiride 4mg

Clinical trial NCT02954822 · COMPLETED

Trial details

NCT number
NCT02954822
Sponsor
Dong-A ST Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type2 Diabetes
Start date
2016-11-14
Primary completion
2017-01-25
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.